Boston Scientific subpoenaed over defibrillator performance

Modern Healthcare

  • Boston Scientific Corp., a Natick, Mass.-based manufacturer of implantable cardiac devices and other medical products, said last week that it was served with a subpoena from HHS' Office of the Inspector General for information about the performance of its defibrillators. The company disclosed the May 5 subpoena in securities filings and said it is cooperating with the request. The government is seeking information about the launch and performance of the Cognis and Teligen line of devices. It also requested material about the operation of what was referred to as a physician-guided learning program.

  • The Pittsburgh-based UPMC health system continued to strengthen its financial position this year in a market that has seen bitter contract disputes and turf wars for patients. Its growth came largely through its insurance division, which is rapidly adding new members; its affiliation with Altoona (Pa.) Regional Hospital; and new revenue streams from outside ventures in the U.S. and abroad. In a financial report for its fiscal third quarter, which ended March 31, the system reported that it had an operating margin of 2.1% in the first nine months of its fiscal year, compared with 1.9% during the same period in fiscal 2013.

  • The University of South Florida, a healthcare research center, has been told to return more than $6 million in federal grants because of allegations in an audit that the school sometimes exercised poor oversight and misspent the money. “The university takes very seriously its obligation to charge only allowable costs to federal awards and respectfully, but strongly, disagrees that its oversight was wanting,” Rebecca Puig, assistant vice president for research and innovation at the University of South Florida, wrote in response to a performance audit by HHS' Office of the Inspector General, which says that about $6.5 million of grants received went to costs that were either impermissible, improperly documented, or not directly related to the grants that paid for them.
    • Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    tariffs-healthcare-money-finance-0225
    How health system CFOs are navigating the growing uncertainty
    value based care integrated
    Evernorth, Optum, CenterWell units buoyed insurers in Q1
    Most Popular
    1
    Here are new state healthcare laws taking effect in 2025
    2
    Meet Modern Healthcare's 2025 Leading Women
    3
    New York-Presbyterian layoffs affect 2% of employees
    4
    Evernorth, Optum, CenterWell units buoyed insurers in Q1
    5
    Epic CEO Judy Faulkner on AI, antitrust and consolidation